People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other, Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Telcare, Inc. | — | Other | Series B | $71.6M | $576.6M | 2012 |
| Brain Corp | — | Other Technology | Series B | $68.3M | $272.3M | 2020 |
| ECPM Holdings, LLC | — | Other | Series B | $56.9M | $515.1M | 2014 |
| Acton Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $21.7M | $216.8M | 2009 |
| Timesight Systems Inc | — | Other Technology | Seed | $7.4M | $3.9M | 2012 |
| Recruit.U Holding Corp | — | Other Technology | Seed | $4.6M | $5.1M | 2025 |
Scott Carter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Carter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Simon | 1 | 11 |
| Scott Davis | 1 | 10 |
| ROBERT GREENE | 1 | 9 |
| David Gill | 1 | 8 |
| Patrick Flynn | 1 | 8 |
| David Kaufman | 1 | 7 |
| Scott Huennekens | 1 | 7 |
| MARK GILREATH | 1 | 6 |
| Uri Geiger | 1 | 6 |
| John Dwyer | 1 | 5 |
| RIK VANDEVENNE | 1 | 5 |
| Robert Rosenberg | 1 | 4 |
| Thomas Uhlman | 1 | 4 |
| Kevin Turner | 1 | 4 |
| Jonathan Javitt | 1 | 3 |
| Harvey White | 1 | 3 |
| Shawn Swaney | 1 | 2 |
| David Bjork | 1 | 2 |
| Casper C. De Clercq | 1 | 2 |
| Steve Altman | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.